Bank of New York Mellon Corp - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 16 filers reported holding BENITEC BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q3 2022$6,000
-64.7%
14,8310.0%0.00%
Q2 2022$17,000
-51.4%
14,831
-0.7%
0.00%
Q1 2022$35,000
-10.3%
14,9320.0%0.00%
Q4 2021$39,000
-26.4%
14,9320.0%0.00%
Q3 2021$53,000
-15.9%
14,9320.0%0.00%
Q2 2021$63,000
-30.8%
14,932
-15.4%
0.00%
Q1 2021$91,00017,6530.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Rosenberg Matthew Hamilton 23$700.00%
View complete list of BENITEC BIOPHARMA INC shareholders